ml-3000 has been researched along with tepoxalin in 1 studies
| Studies (ml-3000) | Trials (ml-3000) | Recent Studies (post-2010) (ml-3000) | Studies (tepoxalin) | Trials (tepoxalin) | Recent Studies (post-2010) (tepoxalin) |
|---|---|---|---|---|---|
| 130 | 9 | 56 | 71 | 14 | 20 |
| Protein | Taxonomy | ml-3000 (IC50) | tepoxalin (IC50) |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | Ovis aries (sheep) | 2.85 | |
| Polyunsaturated fatty acid 5-lipoxygenase | Rattus norvegicus (Norway rat) | 0.6667 | |
| Prostaglandin G/H synthase 2 | Homo sapiens (human) | 2.85 | |
| Prostaglandin G/H synthase 2 | Rattus norvegicus (Norway rat) | 3.525 | |
| Prostaglandin G/H synthase 1 | Rattus norvegicus (Norway rat) | 3.525 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatti, R; Kaur, J; Kumari, P; Singh, P | 1 |
1 other study(ies) available for ml-3000 and tepoxalin
| Article | Year |
|---|---|
Design, Synthesis, and Activity Evaluation of Stereoconfigured Tartarate Derivatives as Potential Anti-inflammatory Agents
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Drug Design; Edema; Female; Humans; Lipoxygenase; Lipoxygenase Inhibitors; Male; Mice; Molecular Structure; Stereoisomerism; Structure-Activity Relationship; Tartrates | 2021 |